4//SEC Filing
Sassi Nir 4
Accession 0001493152-23-002020
CIK 0001857044other
Filed
Jan 19, 7:00 PM ET
Accepted
Jan 20, 4:05 PM ET
Size
5.5 KB
Accession
0001493152-23-002020
Insider Transaction Report
Form 4
Sassi Nir
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2023-01-18+40,000→ 40,000 totalExercise: $1.61Exp: 2033-01-18→ Common Stock (40,000 underlying)
Footnotes (1)
- [F1]The stock option vests and becomes exercisable as to one-third of the total shares on January 18, 2024 and thereafter in equal quarterly installments over the following 24 months, such that the stock option becomes vested and exercisable as to all shares on January 18, 2026.
Documents
Issuer
Indaptus Therapeutics, Inc.
CIK 0001857044
Entity typeother
Related Parties
1- filerCIK 0001760673
Filing Metadata
- Form type
- 4
- Filed
- Jan 19, 7:00 PM ET
- Accepted
- Jan 20, 4:05 PM ET
- Size
- 5.5 KB